You are here

  • Home
  • Archive
  • Volume 19, Issue 5
  • Immunogenicity, Reactogenicity, and Safety of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women: Interim Analysis of a Phase II, Double-blind, Randomized Controlled Trial at Month 7

Citation Tools

Article menu
Download PDFPDF
Cervical Cancer
Immunogenicity, Reactogenicity, and Safety of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women: Interim Analysis of a Phase II, Double-blind, Randomized Controlled Trial at Month 7

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Konno R, Dobbelaere KO, Godeaux OO, et al
Immunogenicity, Reactogenicity, and Safety of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women: Interim Analysis of a Phase II, Double-blind, Randomized Controlled Trial at Month 7
International Journal of Gynecologic Cancer 2009;19:905-911.